These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 5598902)

  • 41. [Animal experimental studies of the effect of synthetic antifibrinolytics].
    Markwardt F; Klöcking HP
    Acta Biol Med Ger; 1966; 17(6):746-54. PubMed ID: 5990894
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comparative studies on antifibrinolytic agents].
    Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):106-12. PubMed ID: 4173870
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
    Skoza L; Tse AO; Semar M; Johnson AJ
    Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
    [No Abstract]   [Full Text] [Related]  

  • 44. Antifibrinolytic activity of epsilon-aminocaproyl derivatives of amino acids.
    Midura-Nowaczek K; Bruzgo I; Dubis E; Roszkowska-Jakimiec W; Worowski K
    Pharmazie; 1996 Oct; 51(10):775-7. PubMed ID: 8941949
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparison of antifibrinolytic effects of epsilon-aminocaproic acid and enzyme inhibitors in the surgery of portal hypertension].
    Lande M; Clot-Paimboeuf C; Dentan T
    Presse Med (1893); 1971 Jan; 79(1):15-6. PubMed ID: 5539954
    [No Abstract]   [Full Text] [Related]  

  • 46. [The inhibitors of fibrinolysis: new information on antifibrinolytic agents].
    Giacomazzi G
    Haematologica; 1968; 53(7):489-533. PubMed ID: 4976851
    [No Abstract]   [Full Text] [Related]  

  • 47. [On the antifibrinolytic activity of the esters of 4-aminomethylbenzoic acid (PAMBA)].
    Markwardt F; Neuland P; Klöcking HP
    Pharmazie; 1966 Jun; 21(6):345-8. PubMed ID: 6000982
    [No Abstract]   [Full Text] [Related]  

  • 48. Investigation and determination of the antifibrinolytic properties of dipeptides and synthetic compounds.
    Dupin JP; Boisseau M; Brasington RD; Mesnard P
    Pathol Biol (Paris); 1978; 26(5):233-9. PubMed ID: 358100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Omega-amino acids and various biogenic amines as antagonists to pentylenetetrazol.
    Kobrin S; Seifter J
    J Pharmacol Exp Ther; 1966 Dec; 154(3):646-51. PubMed ID: 5928260
    [No Abstract]   [Full Text] [Related]  

  • 50. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator. 4. Antifibrinolytic action of sex hormones, especially a conjugated estrogen (Premarin) and its application.
    Mori N; Takemoto J
    Acta Obstet Gynaecol Jpn; 1969 Jul; 16(3):137-42. PubMed ID: 4309742
    [No Abstract]   [Full Text] [Related]  

  • 51. [Antifibrinolytic effect of araliphatic esters and amides of p-aminomethylbenzoic acid].
    Klöcking HP; Knauer H; Markwardt F
    Acta Biol Med Ger; 1973; 30(3):Suppl:K9-13. PubMed ID: 4762328
    [No Abstract]   [Full Text] [Related]  

  • 52. Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.
    Okamoto S; Oshiba S; Mihara H; Okamoto U
    Ann N Y Acad Sci; 1968 Jun; 146(2):414-29. PubMed ID: 5254270
    [No Abstract]   [Full Text] [Related]  

  • 53. Bridged bicyclic and polycyclic amino acids. Potent new inhibitors of the fibrinolytic process.
    Loeffler LJ; Britcher SF; Baumgarten W
    J Med Chem; 1970 Sep; 13(5):926-35. PubMed ID: 5458384
    [No Abstract]   [Full Text] [Related]  

  • 54. [Activity of antifibrinolytics when administered using a direct current].
    Krylov IuF; Loginova VA; Efanov OI
    Farmakol Toksikol; 1978; 41(1):80-2. PubMed ID: 304816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The inhibitors of fibrinolysis].
    Badimón L; Villaverde CA; Bastida E; Badimón JJ; Valdecasas FG
    Arch Farmacol Toxicol; 1978 Apr; 4(1):98-9. PubMed ID: 697408
    [No Abstract]   [Full Text] [Related]  

  • 56. [Complexes of heparin with antiplasmins and several of their properties].
    Pastorova VE; Kudrashov BA; Rodina VI
    Vopr Med Khim; 1973; 19(5):492-7. PubMed ID: 4788172
    [No Abstract]   [Full Text] [Related]  

  • 57. [Heparin and fibrinolysis inhibitors].
    Villaverde CA; Badimón L; Vidal M; Badimón JJ; Valdecasas FG
    Arch Farmacol Toxicol; 1981 Apr; 7(1):97-100. PubMed ID: 7325724
    [No Abstract]   [Full Text] [Related]  

  • 58. [Electron microscope studies of thrombocytes of rabbits before and after administration of epsilon-aminocaproic acid].
    Beznosikova VK; Chaplygina ZA; Beznosikov BO
    Probl Gematol Pereliv Krovi; 1968 Jan; 13(1):32-7. PubMed ID: 5736821
    [No Abstract]   [Full Text] [Related]  

  • 59. [Trypsin inhibition by new antifibrinolytics].
    Gülzow M; Mix H; Trettin HJ
    Hoppe Seylers Z Physiol Chem; 1967 Mar; 348(3):285-8. PubMed ID: 5589206
    [No Abstract]   [Full Text] [Related]  

  • 60. Fibrinolysis.
    Fearnley GR
    Adv Drug Res; 1973; 7():107-63. PubMed ID: 4280240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.